PD
Platt David
董事长兼首席执行官
C-suiteM
内部人交易记录
首席执行官尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Platt David, 董事长兼首席执行官. Officer active across 1 company, notably Bioxytran, INC. Aggregated, 21 reports have been recorded. Split: 1 buy · 0 sell. Total volume traded: €180k. Activity tracked since 4 June 2021. The latest transaction was disclosed on 19 August 2024 (J). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Platt David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报21 总计
14,085,410 股@ €0.2633preferredSEC:0001445815-25-000007:0
14,085,410 股@ €0.263323.9% 占其流量PreferredSEC:0001754429-24-000013:0
82,260 股@ US$0.0050.0% 占其流量preferredSEC:0001754429-24-000004:6
1,592,921 股@ US$0.1241.2% 占其流量commonSEC:0001754429-24-000004:0
21,675,939 股@ US$0.16220.4% 占其流量commonSEC:0001754429-24-000004:1
4,335,188 股@ US$0.80620.3% 占其流量preferredSEC:0001754429-24-000004:2
8,973,405 股@ US$0.0180.9% 占其流量preferredSEC:0001754429-24-000004:3
776,817 股@ US$0.4562.1% 占其流量preferredSEC:0001754429-24-000004:4
411,300 股@ US$0.0010.0% 占其流量commonSEC:0001754429-24-000004:5
43,027,274 股@ US$0.0010.2% 占其流量commonSEC:0001754429-24-000004:7
8,605,455 股@ US$0.0050.2% 占其流量preferredSEC:0001754429-24-000004:8
439,595 股@ US$0.1040.3% 占其流量commonSEC:0001445815-24-000007:0
3,599,289 股@ US$0.1352.9% 占其流量common stockSEC:0001445815-24-000002:0
5,824,741 股@ US$0.1354.8% 占其流量commonSEC:0001445815-23-000019:0
500,000 股@ US$0.320.9% 占其流量common stockSEC:0001445815-23-000018:0
92,000 股@ US$0.320.2% 占其流量commonSEC:0001445815-23-000013:0
6,763,562 股@ US$0.3212.6% 占其流量commonSEC:0001166440-23-000001:0
411,300 股@ US$0.0030.0% 占其流量commonSEC:0001445815-23-000005:0
455,669 股@ US$0.0010.0% 占其流量Common stockSEC:0001166441-22-000002:0
3,201,788 股@ US$0.1383.5% 占其流量CommonSEC:0001539497-22-000081:0
2,973,988 股@ US$0.132.9% 占其流量CommonSEC:0001539497-21-000793:0
About Platt David
PLATT DAVID is Chairman and Chief Executive Officer and CEO of Bioxytran, INC (XNAS). He has 21 filings in total, and within the recent sampled filings, purchases amount to EUR 180012 and sales to EUR 448, over the period from 2021-06-07 to 2025-11-18.